Eton Pharmaceuticals, Inc.

NASDAQ:ETON

8.62 (USD) • At close November 1, 2024
Bedrijfsnaam Eton Pharmaceuticals, Inc.
Symbool ETON
Munteenheid USD
Prijs 8.62
Beurswaarde 222,708,044
Dividendpercentage 0%
52-weken bereik 3.03 - 9.12
Industrie Biotechnology
Sector Healthcare
CEO Mr. Sean E. Brynjelsen
Website https://www.etonpharma.com

An error occurred while fetching data.

Over Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia

Vergelijkbare Aandelen

BioAtla, Inc. logo

BioAtla, Inc.

BCAB

2.09 USD

Akumin Inc. logo

Akumin Inc.

AKU

0.289 USD

Vigil Neuroscience, Inc. logo

Vigil Neuroscience, Inc.

VIGL

3.87 USD

Wave Life Sciences Ltd. logo

Wave Life Sciences Ltd.

WVE

13.83 USD

SAB Biotherapeutics, Inc. logo

SAB Biotherapeutics, Inc.

SABS

3.88 USD

Assembly Biosciences, Inc. logo

Assembly Biosciences, Inc.

ASMB

16.89 USD

Lipocine Inc. logo

Lipocine Inc.

LPCN

6.08 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)